Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Buckingham

Showing results (91-100 of 164) with videos related to

Pageof 17
Sort By:
Nucleic Acids Research|November 11, 1988
Promoter analysis of myosin alkali light chain genes expressed in mouse striated muscleA Cohen, P J Barton, B Robert, et al.
Developmental Cell|May 8, 2004
The clonal origin of myocardial cells in different regions of the embryonic mouse heartSigolène M Meilhac, Milan Esner, Robert G Kelly, et al.
Diabetes|May 20, 1998
Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitroA B Walker, E K Naderali, P D Chattington, et al.
Journal of Molecular and Cellular Cardiology|August 5, 1998
Dynamic left/right regionalisation of endogenous myosin light chain 3F transcripts in the developing mouse heartR G Kelly, P S Zammit, V Mouly, et al.
Circulation Research|June 26, 2004
Right ventricular myocardium derives from the anterior heart fieldStéphane Zaffran, Robert G Kelly, Sigolène M Meilhac, et al.
British Journal of Pharmacology|December 22, 1999
Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilutionL C Pickavance, M Tadayyon, P S Widdowson, et al.
Diabetes|April 30, 2002
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injuryNassirah Khandoudi, Philippe Delerive, Isabelle Berrebi-Bertrand, et al.
International Journal of Cancer|August 9, 1995
Comparison of solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agentsL E Buckingham, M Balasubramanian, R M Emanuele, et al.
Violence Against Women|August 18, 2012
The impact of victim-focused outreach on criminal legal system outcomes following police-reported intimate partner abuseAnne P DePrince, Joanne Belknap, Jennifer S Labus, et al.
Developmental Biology|July 15, 1997
Embryonic and fetal myogenic programs act through separate enhancers at the MLC1F/3F locusR G Kelly, P S Zammit, A Schneider, et al.
Pageof 17

Showing results (91-100 of 164) with videos related to

Sort By:
Pageof 17
Nucleic Acids Research|November 11, 1988
Promoter analysis of myosin alkali light chain genes expressed in mouse striated muscleA Cohen, P J Barton, B Robert, et al.
Developmental Cell|May 8, 2004
The clonal origin of myocardial cells in different regions of the embryonic mouse heartSigolène M Meilhac, Milan Esner, Robert G Kelly, et al.
Diabetes|May 20, 1998
Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitroA B Walker, E K Naderali, P D Chattington, et al.
Journal of Molecular and Cellular Cardiology|August 5, 1998
Dynamic left/right regionalisation of endogenous myosin light chain 3F transcripts in the developing mouse heartR G Kelly, P S Zammit, V Mouly, et al.
Circulation Research|June 26, 2004
Right ventricular myocardium derives from the anterior heart fieldStéphane Zaffran, Robert G Kelly, Sigolène M Meilhac, et al.
British Journal of Pharmacology|December 22, 1999
Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilutionL C Pickavance, M Tadayyon, P S Widdowson, et al.
Diabetes|April 30, 2002
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injuryNassirah Khandoudi, Philippe Delerive, Isabelle Berrebi-Bertrand, et al.
International Journal of Cancer|August 9, 1995
Comparison of solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agentsL E Buckingham, M Balasubramanian, R M Emanuele, et al.
Violence Against Women|August 18, 2012
The impact of victim-focused outreach on criminal legal system outcomes following police-reported intimate partner abuseAnne P DePrince, Joanne Belknap, Jennifer S Labus, et al.
Developmental Biology|July 15, 1997
Embryonic and fetal myogenic programs act through separate enhancers at the MLC1F/3F locusR G Kelly, P S Zammit, A Schneider, et al.
Pageof 17